Annexins: Key regulators of haemostasis, thrombosis, and apoptosis

Thrombosis and Haemostasis

Volumn 86, Issue 1, 2001, Pages 413-419

  Reutelingsperger, C P M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Annexins; Apoptosis; Haemostasis; Membrane phospholipids; Thrombosis

Indexed keywords

ANNEXIN; MEMBRANE PHOSPHOLIPID; PHOSPHATIDYLSERINE;

ANIMAL; APOPTOSIS; ATHEROSCLEROSIS; BINDING AFFINITY; BLOOD CLOTTING; CELL SURFACE; CLINICAL STUDY; CONFERENCE PAPER; CYTOLOGY; DISEASE ACTIVITY; HEMOSTASIS; HUMAN; NONHUMAN; PHAGOCYTOSIS; PHOSPHOLIPID MEMBRANE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN STRUCTURE, FUNCTION AND VARIABILITY; REGULATORY MECHANISM; THROMBOSIS;

EID: 0034912352     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616239     Document Type: Conference Paper

References (109)

1. Annexins: The problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins
2. Annexins and membrane dynamics
3. Annexins
4. 2+-dependent membrane-binding proteins
5. 2+-regulated-phospholipid binding protein
6. A protein terminology tangle
7. Novel human and mouse annexin A10 are linked to the genome duplications during early chordate evolution
8. The crystal and molecular structure of human annexin V, an anticoagulant protein that binds to calcium and membranes
9. The calcium binding sites in human annexin V by crystal structure analysis at 2.0 A resolution. Implications for membrane binding and calcium channel activity
10. The crystal structure of a new high-calcium form of annexin V
11. 2+-bridging mechanism and phospholipid head group recognition in the membrane-binding protein annexin V
12. Placental anticoagulant proteins: Isolation and comparative characterization four members of the lipocortin family
13. 2+-dependent phospholipid binding, vesicle aggregation and membrane fusion by annexins
14. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers
15. Interactions of annexins with membrane phospholipids
16. Different properties of two isoforms of annexin XIII in MDCK cells
17. 2+-regulated association of lipid microdomains
18. Phospholipid determinants for annexin V binding sites and the role of tryptophan 187
19. Surface topography of the p3 and p6 annexin V crystal forms determined by atomic force microscopy
20. Structure of membrane-bound annexin A5 trimers: A hybrid Cryo-EM-X-ray crystallography study
21. Sub-domain structure of lipid-bound annexin-V resolved by electron image analysis
22. Structure of the trigonal crystal form of bovine annexin IV
23. Crystallization of p68 on lipid monolayers and as three-dimensional single crystals
24. Membrane-mediated assembly of annexins studied by site-directed spin labeling
25. 2+-dependent regulators of membrane function
26. The annexins and exocytosis
27. Annexin VI stimulates endocytosis and is involved in the trafficking of low density lipoprotein to the prelysosomal compartment
28. Localization of five annexins in J774 macrophages and on isolated phagosomes
29. Analysis of CD44-containing lipid rafts: Recruitment of annexin II and stabilization by the actin cytoskeleton
30. A series of annexins from human placenta and their characterization by use of an endogenous phospholipase A2
31. 2+-binding site in the mechanism of inhibition
32. Inhibition of protein kinase C by annexin V
33. Annexin V inhibits protein kinase C activity via a mechanism of phospholipid sequestration
34. Voltage dependent binding of annexin V, annexin VI and annexin VII-core to acidic phospholipid membranes
35. Biophysical and molecular properties of annexin-formed channels
36. Annexins V and XII insert into bilayers at mildly acidic pH and form ion channels
37. Decreased concentration of Annexin V in Parkinsonian cerebrospinal fluid: Speculation on the underlying cause
38. Selective secretion of annexin 1, a protein without a signal sequence, by the human prostate gland
39. Lung type II cell and macrophage annexin I release: Differential effects of two glucocorticoids
40. Annexin VI is secreted in human bile
41. Placental anticoagulant protein-I: Measurement in extracellular fluids and cells of the hemostatic system
42. Annexins I to VI: Quantitative determination in different human cell types and in plasma after myocardial infarction
43. Expression and localization of the annexins II, V, and VI in myocardium from patients with end-stage heart failure
44. Recombinant human lipocortin 1 inhibits thromboxane release from guinea-pig isolated perfused lung
45. Lipocortin 1 reduces myocardial ischemia-reperfusion injury by affecting local leukocyte recruitment
46. An endothelial cell receptor for plasminogen tissue plasminogen activator 1. Identity with annexin II
47. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). 2. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation
48. Regulation of plasmin activity by annexin II tetramer
49. Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord
50. Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family
51. The complexity of the phospholipid binding protein annexin V
52. In-vivo antithrombotic potency of placenta protein 4 (annexin V)
53. Annexin V inhibits the procoagulant activity of matrices of TNF-stimulated endothelium under blood flow conditions
54. Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model
55. "Annexinopathies" - A new class of diseases
56. Annexin II and bleeding in acute promyelocytic leukemia
57. Ontogeny of beta 2 glycoprotein I and annexin V in villous placenta of normal and antiphospholipid syndrome pregnancies
58. Pregnancy loss in the antiphospholipid-antibody syndrome - A possible thrombogenic mechanism
59. Annexin V is critical in the maintenance of murine placental integrity
60. Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta
61. Clustering of lipid-bound annexin V may explain its anticoagulant effect
62. Lupus anticoagulant antibodies: Recognition of phospholipid-binding protein complexes
63. Localization of the apoptosis-inducing activity of lupus anticoagulant in an annexin V-binding antibody subset
64. Molecular biology of apoptosis and programmed cell death
65. Cell deaths in normal vertebrate ontogeny
66. Shrinkage necrosis: A distinct mode of cellular death
67. Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics
68. Mitochondrial control of cell death
69. The biochemistry of apoptosis
70. Defying death after DNA damage
71. CD95's deadly mission in the immune system
72. Apoptosis in development
73. A receptor for phosphatidylserine-specific clearance of apoptotic cells
74. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells
75. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages
76. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells
77. Annexin V for flow cytometric detection of phophatidylserine expression on B cells undergoing apoptosis
78. Human neutrophils lose their surface Fc gamma RIII and acquire annexin V binding sites during apoptosis in vitro
79. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl
80. A novel assay for apoptosis - Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V
81. Mechanism of phosphatidylserine exposure, a phagocyte recognition signal on apoptotic T lymphocytes
82. Apoptosis in vascular disease
83. Idendification and functional expression of four isoforms of ATPase II, the putative aminophospholipid translocase. Effect of isoform variation on the ATPase activity and phospholipid specificity
84. Identification of three new members of the phospholipid scramblase gene family
85. Engulfment of apoptotic cells involves the redistribution of membrane phosphatidylserine on phagocyte and prey
86. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine
87. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes
88. Immune clearance of phosphatidylserine-expressing cells by phagocytes. The role of beta2-glycoprotein I in macrophage recognition
89. Complement-dependent clearance of apoptotic cells by human macrophages
90. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: Implications for coagulation events and antigenic spread in systemic lupus erythematosus
91. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection
92. Thrombin generation by apoptotic vascular smooth muscle cells
93. Apoptotic vascular endothelial cell become procoagulant
94. Apoptosis is associated with increased cell surface tissue factor procoagulant activity
95. Phosphatidylserine plasma membrane asymmetry in vivo: A pancellular phenomenon which alters during apoptosis
96. In situ detection of apoptosis during embryogenesis with annexin V: From whole mount to ultrastructure
97. Spatiotemporal distribution of dying neurons during early mouse development
98. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability
99. Apoptosis in human atherosclerosis and restenosis
100. Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques
101. Apoptosis in inflammatory-fibroproliferative disorders of the vessel wall
102. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: A role for apoptosis in plaque thrombogenicity
103. In vivo detection and imaging of phosphatidylserine expression during programmed cell death
104. Radionuclide imaging of acute lung transplant rejection with annexin V
105. Zinc-mediated reduction of apoptosis in cardiac allografts
106. 99mTc annexin V imaging of neonatal hypoxic brain injury
107. Visualisation of cell death in vivo in patients with acute myocardial infarction
108. Cardiomyocyte death induced by myocardial ischemia and reperfusion - Measurement with recombinant human annexin-V in a mouse model
109. Visualisation of cell death